Antibody evolution could guide HIV vaccine development
Thursday, April 4, 2013 - 19:00
in Biology & Nature
Observing the evolution of a particular type of antibody in an infected HIV-1 patient, a study spearheaded by Duke University, including analysis from Los Alamos National Laboratory, has provided insights that will enable vaccination strategies that mimic the actual antibody development within the body.